The House Passes The 21st Century Cures Act – On To The Senate
Last Wednesday the House passed with a vote of 392 to 26, a medical innovation bill known as the 21st Century Cures Act, aimed at curing diseases, with the measure securing bipartisan support after months of [...]
Cognition and Hormone Therapy (ADT)
There have been numerous studies examining the how hormone deprivation (ADT), in the treatment of prostate cancer, has on a man’s cognition. There have been contradictor studies about this issue, however having had the experience [...]
Politics As Usual As Congress Prepares To Not Pass The Budget – A Potential Devastating Problem for Medical Research
It is deeply troubling to learn that Congress is considering not completing the fiscal year 2017 budget appropriations process. Because of the normal political fighting that we still see in Washington, Congress is now considering [...]
Vitamin D3 Potentiates Metformin in DU145 Human Prostate Cancer Cells
It is well established that common drugs like Metformin and vitamin D? exhibit a strong anti-proliferative action in many cancer cell lines. Recent research confirms that this is also true in human prostate cancer cells. [...]
Over 20,000 Have Pledged to Boycott CVS & Caremark until they sell Cancer Drugs Again- CVS removing many cancer drugs, including Xtandi, from it’s formulary
Sign pledge to boycott CVS here: http://bit.ly/2gAJlno CVS Pharmacy will hurt many cancer patients by removing dozens of cancer treatment drugs, like leukemia drug Tasigna, prostate cancer drug Xtandi and chemotherapy treatment drug Neupogen, from [...]
Oncotype DX® Now Validated for Adverse Pathology, Biochemical Recurrence, Metastasis and Prostate Cancer Specific Death
In a press release issued yesterday, Genomic Health Inc. announced topline results from their clinical validation study of its biopsy-based Oncotype DX® Genomic Prostate Score™ (GPS). The study met its primary endpoint by demonstrating that Oncotype DX® [...]